Flash e-reader

 Go to e-reader chapter








PDF FormatRequires Adobe Acrobat Reader

Table 8.6e

Immunosuppression Use for Maintenance

Prior to Discharge, 2000 to 2009

Recipients with Kidney-Pancreas Transplants

  Year of Transplant
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Functioning Graft at Discharge 888 861 881 847 864 884 905 842 820 836
With Immunosuppression Info 886 861 881 844 851 879 891 833 817 821
Corticosteroids Any in Category 97.1% 93.3% 89.7% 83.8% 75.2% 71.0% 66.2% 65.4% 70.1% 69.9%
Prednisone 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Steroids 97.0% 93.3% 89.7% 83.8% 75.2% 71.0% 66.2% 65.4% 70.1% 69.9%
Cyclosporine Any in Category 18.8% 13.7% 9.8% 8.9% 6.2% 6.7% 6.4% 4.6% 4.4% 3.4%
Sandimmmune 1.9% 0.9% 0.8% 0.1% 0.1% 0.2% 0.2% 0.2% 0.5% 0.2%
Neoral 16.1% 10.8% 6.8% 7.2% 5.3% 5.2% 5.4% 3.7% 3.7% 2.7%
Gengraf 0.8% 2.0% 1.9% 1.5% 0.8% 1.3% 0.8% 0.6% 0.2% 0.5%
Eon 0.0% 0.0% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Tacrolimus Any in Category 82.3% 86.6% 90.2% 83.9% 84.6% 88.9% 92.4% 94.4% 94.0% 94.5%
Tacrolimus 82.3% 86.6% 90.2% 83.9% 84.6% 88.9% 92.3% 93.9% 93.3% 94.0%
Everolimus 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.5% 0.7% 0.5%
Antimetabolites Any in Category 84.9% 79.9% 82.2% 82.7% 83.7% 81.8% 85.1% 91.4% 91.1% 91.4%
Mycophenolate Mofetil 82.4% 78.9% 81.2% 81.6% 81.8% 74.6% 71.6% 73.5% 72.5% 64.7%
Mycophenolate Sodium 0.0% 0.0% 0.0% 0.0% 1.5% 6.9% 12.3% 17.2% 18.5% 25.9%
Azathioprine 2.5% 1.0% 1.0% 1.1% 0.4% 0.2% 1.1% 0.7% 0.1% 0.7%
Cytoxan 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
mTOR Inhibitors Any in Category 13.2% 21.4% 18.8% 19.3% 16.8% 15.4% 16.3% 10.3% 8.0% 6.1%
Sirolimus 13.0% 21.4% 18.8% 19.2% 16.8% 15.4% 16.3% 10.3% 8.0% 6.1%
Everolimus 0.2% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%


Source: OPTN/SRTR Data as of October 1, 2010.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.